Orser Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$3.97M |
| 2 |
Zebra Technologies
ZBRA
|
+$2.15M |
| 3 |
Medtronic
MDT
|
+$1.93M |
| 4 |
ProShares Short S&P500
SH
|
+$1.68M |
| 5 |
Pfizer
PFE
|
+$1.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$5.38M |
| 2 |
Baxter International
BAX
|
+$2.43M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.67M |
| 4 |
ProShares Short QQQ
PSQ
|
+$1.46M |
| 5 |
Clorox
CLX
|
+$1.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.25% |
| 2 | Healthcare | 17.04% |
| 3 | Consumer Staples | 10.73% |
| 4 | Financials | 7.43% |
| 5 | Consumer Discretionary | 7.41% |
Similar funds
Orser Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Orser Capital Management held 92 positions worth $158M, up 25% from $127M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Orser Capital Management deployed $18.1M of net new capital in Q4 2020, opening 23 new positions and adding to 39 existing holdings. Its largest new stake was Edwards Lifesciences: 47,875 shares worth $4.37M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $5.38M trimmed.
- Orser Capital Management's largest Q4 2020 buy was Edwards Lifesciences: 47,875 shares worth $4.37M.
- Orser Capital Management added most to ProShares Short S&P500 in Q4 2020, an estimated $1.68M increase.
- Orser Capital Management's biggest Q4 2020 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $5.38M.
- Orser Capital Management fully exited Baxter International in Q4 2020, selling an estimated $2.43M.
- Orser Capital Management's ten largest holdings make up 33% of its $158M portfolio in Q4 2020.
- Orser Capital Management opened 23 new positions and closed 3 in Q4 2020.
- Orser Capital Management's portfolio value rose 25% quarter-over-quarter to $158M.
Based on Orser Capital Management's 13F filing for Q4 2020, filed 2 Feb 2021.